The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1207-1214

  Low, Jennifer A ^a,b   Johnson, Michael D ^a,b   Bone, Elisabeth A ^c   Dickson, Robert B ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c British Biotechnology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; COLLAGENASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER TRANSPLANTATION; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SOLID TUMOR; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCITES; FEMALE; GELATINASES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHENYLALANINE; PROTEASE INHIBITORS; THIOPHENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029888124     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
2. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. Matrix metalloproteinases: a review. Crit Rev. Oral Biol. Med., 4: 197-250, 1993.
3. Stetler-Stevenson, W. G., Liotta, L. A., and Kleiner, D. E., Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7: 1434-1441, 1993.
4. Khokha, R., Zimmer, M. J., Graham, C. H., Lala, P. K., and Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl. Cancer Inst., 84: 1017-1022, 1992.
5. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52: 701-708, 1992.
6. Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., and Denhardt, D. T. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (Washington DC), 243: 947-950, 1989.
7. Davies, B., Brown, P. D., East, N., Crimmin, M. J., and Balkwill, F. R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res., 53: 2087-2091, 1993.
8. Chirivi, R. G. S., Garofalo, A., Cnmmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., and Giavazzi, R. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer, 58: 460-464, 1994.
9. Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D., and Hardcastle, J. D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in human colon carcinoma metastasis models. Cancer Res., 55: 3629-3633, 1995.
10. Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res., 54: 4726-4728, 1994.
11. Taraboletti, G, Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D., and Giavazzi, R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst., 87: 293-298, 1995.
12. Price, J. E., Polyzos, A., Zhang, R. D., and Daniels, L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res., 50: 717-721, 1990.
13. Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150: 534-544, 1992.
14. MDR1: ascites models of human breast cancer. Br. J. Cancer, 73: 154-161, 1996.
15. Heussen, C., and Dowdle, E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102: 196-202, 1980.
16. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res., 54: 4791-4797, 1994.
17. Sledge, G. W., Qulali, M., Goulet, R., Bone, E. A., and Fife, R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic nude mice. J. Natl. Cancer Inst., 87: 1546-1550, 1995.
18. Nagy, J. A., Herzberg, K. T., Dvorak, J. M., and Dvorak, H. F. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation Cancer Res., 53: 2631-2643, 1993.
19. Nagy, J. A , Masse, E. M., Herzberg, K. T., Meyers, M. S., Yeo, K-T., Yeo, T-K., Sioussat, T. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
20. Nagy, J. A , Meyers, M. S., Masse, E. M., Herzberg, K. T., and Dvorak, H. F. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res., 55: 369-375, 1995.
21. Nagy, J. A , Morgan, E. S., Herzberg, K. T., Manseau, E J , Dvorak, A. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res., 55: 376-385, 1995.
22. Autio-Harmainen, H., Karttunen, T., Hurskainen, T., Höyhtyä, M., Kauppila, A , and Tryggvason, K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors Lab. Invest., 69: 312-321, 1993.
23. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, T., and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells Oncogene, 7. 77-83, 1992
24. Abe, T., Mon, T., Kohno, K., Seiki, M., Hayakawa, T., Welgus, H. G., Hori, S., and Kuwano, M. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin. & Exp. Metastasis, 12: 296-304, 1994.
25. Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
26. Nakajima, M., Welch, D. R., Belloni, P. N., and Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47. 4869-4876, 1987.
27. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53: 140-146, 1993.
28. Azzam, H. S., Arand, G., Lippman, M. E., and Thompson, E. W. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst , 85: 1758-1764, 1993.
29. Brown, P. D. Matrix metalloproteinase inhibitors: a new class of anticancer agent. Curr. Opin. Invest. Drugs, 2: 617-626, 1993.
30. Masure, S., Nys, G , Fiten, P., Van Damme, J., and Opdenakker, G. Mouse gelatinase B: cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur. J. Biochem., 218: 129-141, 1993.
31. Tanaka, H., Hojo, K., Yoshida, H., Yoshioka, T., and Sugita, K. Molecular cloning and expression of the mouse 105 kDa gelatinase cDNA. Biochem. Biophys. Res. Commun., 190: 732-740, 1993.
32. Miyagi, E., Yasumitsu, H., Hirahara, F., Nagashima, Y., Minaguchi, H., Miyazaki, K., and Umeda, M. Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Clin. & Exp. Metastasis, 13: 89-96, 1995.
33. Himelstein, B. P., Canetesoler, R., Bernhard, E. J., and Mushel, R. J. Induction of fibroblast 92 kDa gelatinase type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci., 107: 477-486, 1994.
34. Soini, Y., Hurskainen, T., Höyhtyä, M., Oikarinen, A., and Autio-Harmainen, H. 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer - a study by in situ hybridization J. Histochem. Cytochem., 42: 945-951, 1994.
35. Noel, A., Emonard, H., Polette, M., Birembaut, P., and Foidart, J. M. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol. Res. Pract., 190: 934-941, 1994.
36. Polette, M., Gilbert, N., Stas, I., Nawrocki, B., Noel, A., Remade, A., Stetler-Stevenson, W. G., Birembaut, P., and Foidart, M. Gelatinase A expression and localization in human breast cancers - an in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch., 424: 641-645, 1994.
37. Thompson, E. W., Yu, M., Bueno, J., Jin, L., Maiti, S. N., Palao-Marco, F. L., Pulyaeva, H., Tamborlane, J. W., Tirgari, R., Wapnir, I., and Azzam, H. Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res. Treat., 31. 357-370, 1994